Quick Answer
Guardant Health, Inc. reported Stockholders Equity of -$99.31 million for the year ending 2025.
- Guardant Health, Inc. showed an increase of +28.9% in Stockholders Equity from 2024 to 2025.
- This data is from Guardant Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $296.85 million | Q2 2018: $276.78 million | Q3 2018: $255.19 million | Q1 2019: $468.13 million | Q2 2019: $815.47 million | Q3 2019: $815.40 million | Q1 2020: $785.11 million | Q2 2020: $1.11 billion | Q3 2020: $1.09 billion | Q1 2021: $847.05 million | Q2 2021: $788.07 million | Q3 2021: $709.42 million | Q1 2022: $533.04 million | Q2 2022: $319.09 million | Q3 2022: $166.75 million | Q1 2023: -$44.55 million | Q2 2023: $292.73 million | Q3 2023: $228.30 million | Q1 2024: $68.29 million | Q2 2024: -$1.61 million | Q3 2024: -$60.10 million | Q1 2025: -$250.79 million | Q2 2025: -$305.48 million | Q3 2025: -$354.47 million.
- Over the full 11 years of available data (2015 to 2025), Guardant Health, Inc.'s Stockholders Equity has declined by 219.0%.
- Historical annual values: Fiscal year 2025: -$99.31 million | Fiscal year 2024: -$139.65 million | Fiscal year 2023: $158.68 million | Fiscal year 2022: $60.18 million | Fiscal year 2021: $645.01 million | Fiscal year 2020: $1.30 billion | Fiscal year 2019: $798.39 million | Fiscal year 2018: $483.15 million | Fiscal year 2017: $308.61 million | Fiscal year 2016: $79.70 million | Fiscal year 2015: $83.44 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: